Formula: | C17H17N3O7S |
Molecular Weight: | 407.40 |
Rotatable Bond Donors: | 7 |
clogP: | 1.86 |
Topological Polar Surface Area: | 132.75 |
Lipinski's RO5: | MW: 407.40 HBA: 10 HBD: 2 RB: 7 LogP: 1.86 |
Rule of Three: | MW: 407.40 HBA: 10 HBD: 2 RB: 7 LogP: 1.86 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS24234 | 0.74 | EOS24234 RDKit 3D 27 29 0 0 0 0 0 0 0 0999 V2000 -3.1912 -3.6183 -2.0323 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4943 -3.2469 -0.8482 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.4624 -1.8894 -0.6743 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0454 -0.9950 -1.5766 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9769 0.3849 -1.3746 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5335 1.2996 -2.2270 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.0424 0.6850 -3.4053 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3185 0.8719 -0.2405 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1627 2.2792 -0.0243 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.7806 2.9765 -0.7572 S 0 0 0 0 0 0 0 0 0 0 0 0 -0.5207 2.3751 -2.0505 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.8327 4.4145 -0.5848 O 0 0 0 0 0 0 0 0 0 0 0 0 0.6175 2.4684 0.2465 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3648 3.1741 1.1743 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3391 2.2970 1.6983 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1553 1.0828 1.0735 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8489 -0.1749 1.2156 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3922 -1.2910 0.3561 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0228 -2.4583 0.4864 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1330 -2.6048 1.4497 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7103 -3.6831 1.5539 O 0 0 0 0 0 0 0 0 0 0 0 0 4.4431 -1.4722 2.1771 N 0 0 0 0 0 0 0 0 0 0 0 0 3.8172 -0.2626 2.0732 N 0 0 0 0 0 0 0 0 0 0 0 0 1.1157 1.1805 0.1919 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7453 -0.0083 0.6734 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8117 -1.3814 0.4548 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0418 -2.4033 1.6095 Cl 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 1 0 6 7 1 0 5 8 2 0 8 9 1 0 9 10 1 0 10 11 2 0 10 12 2 0 10 13 1 0 13 14 2 0 14 15 1 0 15 16 2 0 16 17 1 0 17 18 1 0 18 19 2 0 19 20 1 0 20 21 2 0 20 22 1 0 22 23 1 0 16 24 1 0 8 25 1 0 25 26 2 0 26 27 1 0 26 3 1 0 24 13 1 0 23 17 2 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |